PMID: 9529535Apr 8, 1998Paper

Tissue engineering in urologic surgery

The Urologic Clinics of North America
A Atala

Abstract

The use of nonurologic tissues in the genitourinary tract is common (owing to a lack of a better alternative) despite the known possible adverse effects. Selective cell transplantation is providing a means to engineer genitourinary tissues that may be used for reconstruction. This novel technology involves an interdisciplinary approach, combining techniques of cell biology and materials sciences towards the development of functional tissues or organs. Tissues associated with urology, such as clitoral, cavernosal, urethral, vesical, ureteral, and renal have been created in the laboratory, with varying degrees of function. Cells have also been recently used in patients as bulking agents for the treatment of vesicoureteral reflux and urinary incontinence. As the science of tissue engineering evolves, one can expect a wider application of this technology to the armamentarium of urologic surgery.

References

Jan 1, 1992·Scandinavian Journal of Urology and Nephrology·L OlsenI Eriksson
Jan 1, 1992·Progress in Growth Factor Research·S A Prigent, N R Lemoine
Sep 28, 1990·Science·R Langer
Jul 7, 1984·British Medical Journal·B O'Donnell, P Puri
Aug 1, 1995·Journal of Biomedical Materials Research·D J MooneyR Langer
Mar 25, 1994·Science·N A Peppas, R Langer
Aug 1, 1996·The Journal of Urology·P E LevesqueA B Retik
Apr 1, 1997·British Journal of Urology·M ProbstE A Tanagho
Sep 5, 1993·Biotechnology and Bioengineering·A G MikosR Langer
Mar 25, 1994·Biotechnology and Bioengineering·D A Cieslinski, H David Humes

❮ Previous
Next ❯

Citations

Mar 23, 1999·The Urologic Clinics of North America·R T Kershen, A Atala
Mar 18, 2000·Biomaterials·J L ParienteM Le Guillou
Jan 28, 2003·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·Philippe Grise
Feb 15, 2000·BJU International·M ProbstE A Tanagho
Apr 12, 2001·BJU International·M I Liu, J M Hutson
Mar 14, 2002·Journal of Endourology·Mario SoferJohn D Denstedt
Sep 9, 2004·Current Opinion in Obstetrics & Gynecology·Narender N Bhatia, Mat H Ho
Feb 15, 2012·Annals of Surgery·Giuseppe OrlandoShay Soker
Mar 22, 2014·Journal of Pediatric Surgery·Nastaran SabetkishSeyyed Mohammad Tavangar
Sep 10, 2008·BJU International·Michael MitterbergerJosef Oswald
Jun 7, 2006·Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy
May 29, 2000·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·H XieK W Gregory
Apr 13, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Toshio TakagiKazunari Tanabe
Aug 13, 1998·Nature Medicine·B R Unsworth, P I Lelkes
Mar 3, 1999·Nature Biotechnology·C Lorenz, B M Schaefer
May 27, 2014·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Mingshuai WangNianzeng Xing
Dec 27, 2011·The International Journal of Artificial Organs·Bai-Song ChenFang Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.